论文部分内容阅读
目的评价综合介入治疗中晚期肝癌的临床效果。方法将2011年6月至2012年9月在我院接受治疗的58例中晚期肝癌患者通过抽签的方法划分为两组。观察组进行TACE+RFA治疗,对照组通过TACE进行治疗,将两组患者手术后肿瘤缩小率、甲胎蛋白下降情况进行统计分析,比较两种治疗方法的疗效。结果观察组患者肿瘤缩小率、甲胎蛋白降低50%的比例明显优于对照组。结论 TACE+RFA能够有效治疗中晚期肝癌,提高患者的生存质量,是治疗中晚期肝癌的有效综合介入治疗方法。
Objective To evaluate the clinical effect of comprehensive interventional treatment of advanced liver cancer. Methods From June 2011 to September 2012 in our hospital for treatment of 58 cases of advanced liver cancer patients by lottery method is divided into two groups. The observation group was treated with TACE + RFA, while the control group was treated by TACE. The tumor shrinkage rate and the decline of α-fetoprotein in the two groups were statistically analyzed. The curative effect of the two treatment methods was compared. Results The tumor shrinkage rate in the observation group was significantly lower than that in the control group with 50% reduction of alpha-fetoprotein. Conclusion TACE + RFA can effectively treat advanced hepatocellular carcinoma and improve the quality of life of patients. It is an effective and comprehensive interventional treatment for advanced hepatocellular carcinoma.